Patent 9327028 was granted and assigned to Cumberland Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.
A pharmaceutical composition and method for providing a reduction in side effects for human patients in need of therapy comprising the administration of a pharmaceutical composition comprising acetylcysteine is disclosed.